Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Carcinoma Metastatic in the Bone”

117 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 117 results

Not applicableStudy completedNCT01833208
What this trial is testing

Radiation Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-T

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Malignant Neoplasm in the BoneRecurrent Prostate Carcinoma+1 more
Roswell Park Cancer Institute 15
Testing effectiveness (Phase 2)Study completedNCT03204812
What this trial is testing

Durvalumab and Tremelimumab in Treating Chemotherapy Naive Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneProstate Adenocarcinoma+3 more
M.D. Anderson Cancer Center 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT03821792
What this trial is testing

Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate CarcinomaProstate AdenocarcinomaProstate Carcinoma Metastatic in the Bone+3 more
M.D. Anderson Cancer Center 60
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02797964
What this trial is testing

A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer

Who this might be right for
Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL)
Sierra Oncology LLC - a GSK company 107
Early research (Phase 1)Study completedNCT03751436
What this trial is testing

Enzalutamide With Venetoclax in Treating Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+6 more
Roswell Park Cancer Institute 10
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Ended earlyNCT00019695
What this trial is testing

Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Stage IV Prostate CancerBone MetastasesAdenocarcinoma of the Prostate+1 more
National Cancer Institute (NCI)
Not applicableLooking for participantsNCT04489719
What this trial is testing

Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Prostate Carcinoma+1 more
University of Washington 48
Not applicableEnded earlyNCT05301062
What this trial is testing

A Research Called CREDIT Studies How Safe the Study Treatment Radium-223 is and How Well it Works in Chinese Men With Advanced Prostate Cancer That Has Spread to the Bones and Does Not Respond to Treatments for Lowering Testosterone Levels

Who this might be right for
Metastatic Castration-resistant Prostate CancerBone Metastases
Bayer 8
Post-approval studies (Phase 4)Study completedNCT00859027
What this trial is testing

Effect Of Risedronate On Bone Mass In Older Men Receiving Neoadjuvant Therapy For Prostate Cancer

Who this might be right for
Prostate Cancer
UConn Health 50
Testing effectiveness (Phase 2)Study completedNCT02512458
What this trial is testing

Study of the Effect of Chemotherapy With Cabazitaxel on Prostate Cancer

Who this might be right for
Bone Metastatic Prostate Cancer
Hellenic Cooperative Oncology Group 60
Early research (Phase 1)Study completedNCT02223052
What this trial is testing

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

Who this might be right for
Hematological NeoplasmsNon-Hodgkin's LymphomaHodgkin's Lymphoma+17 more
Celgene 89
Testing effectiveness (Phase 2)Ended earlyNCT00753220
What this trial is testing

Safety Study of Autologous Dendritic Cells Injected Into the Prostate After Cryoablation for Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Bostwick Laboratories 7
Testing effectiveness (Phase 2)Looking for participantsNCT07292168
What this trial is testing

A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1

Who this might be right for
Renal Cell Carcinoma MetastaticProstate Cancer MetastaticNon-small Cell Lung Cancer Metastatic+2 more
Kidney Cancer Research Bureau 58
Very early researchEnded earlyNCT00499733
What this trial is testing

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Testing effectiveness (Phase 2)Study completedNCT02384382
What this trial is testing

A Positron Emission Tomography/Computed Tomography (PET/CT) Bone Imaging Study in Patients Receiving Enzalutamide for Castration-Resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate Carcinoma Metastatic to the BoneCastration Resistant Prostate Cancer
Pfizer 23
Not applicableUnknownNCT03134261
What this trial is testing

Diagnostic Imaging of Bone Metastases in Prostate Cancer Patients

Who this might be right for
Prostate Cancer Metastatic to Bone
Herlev Hospital 300
Testing effectiveness (Phase 2)Study completedNCT02507570
What this trial is testing

Open Label Phase Two Study of Enzalutamide With Concurrent Administration of Radium Ra 223 Dichloride in Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Symptomatic Bone Metastasis

Who this might be right for
Prostate Carcinoma Metastatic to the Bone
Carolina Research Professionals, LLC 40
Testing effectiveness (Phase 2)Looking for participantsNCT04071236
What this trial is testing

Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy

Who this might be right for
Metastatic Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Malignant Neoplasm in the Lymph Nodes+1 more
National Cancer Institute (NCI)
Load More Results
90